Sponsored by
NovaBiotics a step closer to licensing
NOVABIOTICS, a biotechnology firm spun out from Aberdeen University, yesterday revealed it was at an "advanced stage" in appointing a financial adviser to value its first drug.
The company, which raised 5 million from investors earlier this year, plans to licence the development of Novexatin – a treatment for nail fungal infections – or find a development partner.
NovaBiotics said yesterday that the first patients had successfully completed the phase IIa trial of Novexatin.
Founder Dr Deborah O'Neil said the drug had completed the trial with "no safety issues".
Email to a friend
Print this page
Looking for...
Featured advertisers
Jobs
Search for a job
Motors
Search for a car
Property
Search for a house
Weather for Edinburgh
Wednesday 23 May 2012
Today
Sunny spells
Temperature: 11 C to 21 C
Wind Speed: 13 mph
Wind direction: North east
Tomorrow
Sunny spells
Temperature: 12 C to 21 C
Wind Speed: 10 mph
Wind direction: North east
